# FDA Inspection 1208694 - Paul W. Wallace, MD - June 16, 2023

Source: https://www.keypedia.com/records/fda_inspections/paul-w-wallace-md/cc70216d-4369-48ff-9af7-c83ad66217f1
Source feed: FDA_Inspections

> FDA Inspection 1208694 for Paul W. Wallace, MD on June 16, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1208694
- Company Name: Paul W. Wallace, MD
- Inspection Date: 2023-06-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1307736 - 2026-03-17](https://www.keypedia.com/records/fda_inspections/paul-w-wallace-md/f6ed70f6-0bc5-4521-9c11-8fcd6786192e)
- [FDA Inspection 1055969 - 2018-06-08](https://www.keypedia.com/records/fda_inspections/paul-w-wallace-md/3527f127-26e3-41e1-9e59-f8fa618a9260)

Company: https://www.keypedia.com/companies/paul-w-wallace-md/c6e736a3-93ff-4b83-aa9d-86fb904877ca

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c